(Q37785812)

23 August 2017

title

Targeting integrins in malignant glioma (English)

1 reference

23 August 2017

Ghazaleh Tabatabai

1

0 references

Michael Weller

2

object named as

Michael Weller

1 reference

23 August 2017

5

David Reardon

1 reference

23 August 2017

6

Tom Mikkelsen

1 reference

23 August 2017

Burt Nabors

3

1 reference

23 August 2017

Martin Picard

4

1 reference

23 August 2017

Curzio Ruegg

7

1 reference

23 August 2017

Roger Stupp

8

1 reference

23 August 2017

publication date

4 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

175-181

1 reference

https://scigraph.springernature.com/pub.10.1007/s11523-010-0156-3

23 August 2017

exact match

0 references

cites work

Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11523-010-0156-3

Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11523-010-0156-3

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

12 December 2020

Will integrin inhibitors have proangiogenic effects in the clinic?

1 reference

12 December 2020

Vascular integrins: therapeutic and imaging targets of tumor angiogenesis

1 reference

12 December 2020

Tumor response to radiotherapy regulated by endothelial cell apoptosis

1 reference

12 December 2020

Integrin alpha 6 regulates glioblastoma stem cells

1 reference

12 December 2020

The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature

1 reference

12 December 2020

Integrins in angiogenesis and lymphangiogenesis

1 reference

12 December 2020

Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways

1 reference

12 December 2020

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency

1 reference

12 December 2020

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature

1 reference

12 December 2020

Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience

1 reference

12 December 2020

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

1 reference

12 December 2020

Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins

1 reference

12 December 2020

Integrin inhibitors reaching the clinic

1 reference

12 December 2020

Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma

1 reference

12 December 2020

An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.

1 reference

12 December 2020

Hypoxia, gene expression, and metastasis

1 reference

12 December 2020

Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting

1 reference

12 December 2020

alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin.

1 reference

12 December 2020

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

1 reference

12 December 2020

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

12 December 2020

CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.

1 reference

12 December 2020

1 reference

12 December 2020

Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.

1 reference

12 December 2020

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

1 reference

12 December 2020

Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

1 reference

12 December 2020

Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

1 reference

12 December 2020

Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand

1 reference

12 December 2020

Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist

1 reference

12 December 2020

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

1 reference

12 December 2020

Vascular integrins in tumor angiogenesis: mediators and therapeutic targets

1 reference

12 December 2020

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma

1 reference

12 December 2020

Molecular determinants of glioma cell migration and invasion.

1 reference

12 December 2020

Integrins in cancer: biological implications and therapeutic opportunities

1 reference

12 December 2020

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy

1 reference

12 December 2020

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

1 reference

12 December 2020

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

1 reference

12 December 2020

Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy

1 reference

12 December 2020

Enhanced radiation damage of tumor vasculature by mTOR inhibitors

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

1 reference

12 December 2020

10.1007/S11523-010-0156-3

Identifiers

DOI

1 reference

23 August 2017

1 reference